We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Firms Rethinking Design of Drug-Eluting Stents After Data Shows Increased Clot Risk
Firms Rethinking Design of Drug-Eluting Stents After Data Shows Increased Clot Risk
September 15, 2006
One of the largest drug-eluting stent makers, Boston Scientific, is looking at the way it designs these devices after new clinical trial analyses linked them to an increased risk of blood clots.